您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Coronarin A
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Coronarin A
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Coronarin A图片
CAS NO:119188-33-9
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
Coronarin A 是一种具有口服活性的天然物,可抑制mTORC1S6K1增加 IRS1 活性。Coronarin A 具有抗炎活性,也可用于糖尿病的研究。
生物活性

Coronarin A is an orally active natural compound that inhibitsmTORC1andS6K1to increase IRS1 activity. Coronarin A shows anti-inflammatory activity and can also be used for type 2 diabetes mellitus research[1].

IC50& Target[1]

mTORC1

 

S6K1

 

体外研究
(In Vitro)

Coronarin A (3-30 μM; 4 or 12 h) stimulates glycogen synthesis through activating PI3K/Akt/GSK3β signaling and inhibits gluconeogenesis by activating ERK-dependent Wnt/β-catenin/TCF7L2 pathway in rat primary hepatocytes[1].
Coronarin A (1-30 μM; 4 h) increases tyrosine phosphorylation of IRS1 through inhibiting mTOR/S6K1 signaling[1].

Western Blot Analysis[1]

Cell Line:Primary rat hepatocytes
Concentration:1, 3, 10 and 30 μM
Incubation Time:4 h
Result:Increased the Akt and GSK3β phosphorylation dose-dependently. Dose-dependently stimulated the phosphorylation of both ERK1 and ERK2. Increased the phosphorylation of β-catenin and mitogen-activated protein kinase kinase (MEK). Dose-dependently enhanced the tyrosine phosphorylation of IRS1 at Tyr1222, whereas the serine phosphorylation of IRS1 was dose-dependently inhibited. Reduced the phosphorylation of mTOR, S6K1 and S6.

Cell Viability Assay[1]

Cell Line:Primary rat hepatocytes
Concentration:1, 3, 10, 30, 100 and 300 μM
Incubation Time:5.5 h or 12 h
Result:Showed no toxicity at 1-30 μM, decreased cell viability after 12 h incubation at 100 μM.
体内研究
(In Vivo)

Coronarin A (30 or 100 mg/kg; i.p. or p.o.; once daily for 22 days) ameliorates hyperglycemia in mice[1].
Coronarin A (100 mg/kg; p.o.; once daily for 22 days) inhibits the mTOR/S6K1 pathway to activate PI3K/Akt and ERK/β-catenin signaling in livers ofob/obmice[1].
Pharmacokinetic properties of Coronarin A after single administrationainob/obmice[1].

Coronarin At1/2(h)tmax(h)Cmax(ng/mL)AUC0-t(ng·h/mL)AUC0-∞(ng·h/mL)MRT (h)
i.p.14.81.0107345711104521.7
p.o.3.011.0388169418564.88

Data are presented as the mean of three mice.
aCoronarin A was intraperitoneally or orally administered at 30 mg/kg to ob/ob mice.

Animal Model:Maleob/obmice[1]
Dosage:30 mg/kg (IP) or 100 mg/kg (PO)
Administration:Oral or intraperitoneal administration, once daily for 22 days
Result:Significantly decreased the non-fasting and fasting blood glucose. Significantly reduced the serum insulin concentration at 15 min after glucose loading, reduced the average daily food intake while the body weight was unaffected. Increased hepatic glycogen content and the expression levels of gluconeogenic genePck1andG6pcwere significantly decreased.
Animal Model:Femaleob/obmice[1]
Dosage:30 mg/kg
Administration:Intraperitoneal or oral administration (Pharmacokinetic Analysis)
Result:Intraperitoneal injection exhibited higher plasma exposure than oral gavage at the same dose of 30 mg/kg, with Cmaxvalue of 1073 and 388 ng/mL, respectively.
分子量

300.44

Formula

C20H28O2

CAS 号

119188-33-9

结构分类
  • Others
来源
  • Plants
  • Zingiberaceae
  • Hedychium coronariumKoen.
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.